Cargando…
Targeting Glioma with a Dual Mode Optical and Paramagnetic Nanoprobe across the Blood-brain Tumor Barrier
In brain tumors, delivering nanoparticles across the blood-tumor barrier presents major hurdles. A clinically relevant MRI contrast agent, GdDOTA and a near-infrared (NIR) fluorescent dye, DL680 were conjugated to a G5 PAMAM dendrimer, thus producing a dual-mode MRI and NIR imaging agent. Systemic d...
Autores principales: | Karki, Kishor, Ewing, James R, Ali, Meser M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042151/ https://www.ncbi.nlm.nih.gov/pubmed/27695645 http://dx.doi.org/10.4172/2157-7439.1000395 |
Ejemplares similares
-
MRI Monitoring of Cerebral Blood Flow after the Delivery of Nanocombretastatin across the Blood Brain Tumor Barrier
por: Gonawala, Sunalee, et al.
Publicado: (2018) -
Retro-enantio isomer of angiopep-2 assists nanoprobes across the blood-brain barrier for targeted magnetic resonance/fluorescence imaging of glioblastoma
por: Xie, Ruoxi, et al.
Publicado: (2021) -
Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas
por: Gould, Andrew, et al.
Publicado: (2021) -
Dendrimer-Based Nanomedicine (Paramagnetic Nanoparticle, Nanocombretastatin, Nanocurcumin) for Glioblastoma Multiforme Imaging and Therapy
por: Brown, Stephen L, et al.
Publicado: (2021) -
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells
por: Sarin, Hemant, et al.
Publicado: (2008)